ArticleInternational journal of general medicine2025
Pan-Immune-Inflammatory Value Predicts the Risk of Myocardial Infarction Among Patients with Unstable Angina Pectoris and the Outcomes After Percutaneous Coronary Intervention.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study investigates the potential of the pan-immune-inflammatory value (PIV) as a predictive indicator for myocardial infarction (MI) risk in unstable angina pectoris (UAP) patients and its association with major adverse cardiovascular events (MACE) after percutaneous coronary intervention (PCI). Methods: UAP patients diagnosed with MI underwent PCI and were monitored for MACE, including mortality, recurrent MI, revascularization, cerebrovascular accidents, and heart failure admissions. Clinical profiles and PIV levels were recorded. Multivariate logistic regression and receiver operating characteristic (ROC) analyses were conducted to identify variables associated with MI and MACE risk. Results: MI patients had higher PIV (409.07 ± 127.63 vs 284.44 ± 126.96 × 10 Conclusion: PIV is independently associated with MI risk in UAP patients and MACE following PCI. Combining PIV with lipid markers may enhance clinical risk assessment and inform management strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.